Results 121 to 130 of about 16,373 (205)

A six-pronged approach to manage a Plasmodium vivax outbreak in a low- and middle-income country on the road to malaria elimination. [PDF]

PLoS Negl Trop Dis
Labadie-Bracho M, Baldewsingh GK, Hiwat van Laar H, Adhin MR.   +3 more
europepmc   +1 more source

Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]

Malar J
Edler P, Rajasekhar M, Price DJ, Adam I, Awab GR, Barber BE, Brasil LW, Chamma-Siqueira NN, Chu CS, Cui L, Daher A, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Manning L, Mekonnen DA, Monteiro WM, Moore BR, Nosten F, Pasaribu AP, Pereira DB, Poespoprodjo JR, Pukrittayakamee S, Rijal KR, Saravu K, Siqueira AM, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Yeshiwondim AK, Zuluaga-Idarraga LM, Guerin PJ, Simpson JA, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.   +47 more
europepmc   +1 more source

Glucose-6-phosphate dehydrogenase variants in Kachin, Myanmar. [PDF]

Parasites Hosts Dis
Moon Z, Aung JM, VanBik D, Yun HS, Lee S, Dinzouna-Boutamba SD, Ring Z, Hong Y, Chung DI, Goo YK.   +9 more
europepmc   +1 more source

Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan. [PDF]

Malar J
Qurashi B, Zaidi SE, Mushtaque M, Faisal A, Haroon Z, Agha B, Hammal N, Hameed A, Raza A, Ali U, Khan A, Jabbar FA, Adam ZR, Mehmood T, Price RN, Ghanchi N, Thriemer K, Beg MA.   +17 more
europepmc   +1 more source

<i>Plasmodium vivax</i> Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand. [PDF]

Open Forum Infect Dis
Chu CS, Lwin KM, Burgoine K, Phyo AP, Turner C, San T, Aung AA, Win HH, Htoo K, Soe NL, Christina N, Than HH, Dah N, Pilaseng K, Wiladpaingern J, Proux S, Mukaka M, Parker DM, Carrara VI, Nosten F, White NJ.   +20 more
europepmc   +1 more source

Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates. [PDF]

RSC Adv
Monika, Sharma B, Awasthi SK.
europepmc   +1 more source

Safety and Efficacy of 3 Alternative Regimens Against Relapsing Plasmodium vivax Malaria in Glucose 6-Phosphate Dehydrogenase-Deficient Patients in the Brazilian Amazon (ALTPRIM). [PDF]

Clin Infect Dis
Barbosa L, Brito-Sousa J, Nascimento C, Pacheco A, Alexandre M, Alencar A, Melo M, Omena A, Souza I, Silva E, Queiroz M, Siqueira V, Rabelo C, Baía-da-Silva D, Silva D, Rocha Y, Barbosa A, Castro R, Almeida A, Brito M, Lopes A, Balieiro A, Costa M, Amaral T, Valle C, Vieira A, Gonzaga J, Pereira D, Alecrim M, Monteiro W, Lacerda M, Melo G.   +31 more
europepmc   +1 more source

Unite against Malaria: challenges and achievements in malaria control around the globe. [PDF]

Nat Commun
europepmc   +1 more source

Batch Synthesis of Primaquine Diphosphate Anti-Malarial Drug. [PDF]

Chemistry
Akwi FM, Swartbooi S, Watts P.
europepmc   +1 more source

Radical Cure of Plasmodium vivax With Primaquine and CYP2D6 Polymorphism in Southeast Asia. [PDF]

Clin Infect Dis
Baird JK.
europepmc   +1 more source